Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU – Get Free Report)’s stock price shot up 1% during mid-day trading on Monday . The stock traded as high as $10.58 and last traded at $10.58. 754 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 33,128 shares. The stock had previously closed at $10.48.
Drugs Made in America Acquisition Stock Up 1.0%
The company has a 50 day moving average price of $10.51 and a 200 day moving average price of $10.42.
About Drugs Made in America Acquisition
Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
Read More
- Five stocks we like better than Drugs Made in America Acquisition
- What Investors Need to Know to Beat the Market
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- Financial Services Stocks Investing
- The Best Local Butchers for Thanksgiving [2025 Survey]
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Receive News & Ratings for Drugs Made in America Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drugs Made in America Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
